Z-2444-2021 Class II Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-2444-2021 was initiated by Roche Diagnostics Operations, Inc. on Jun 24, 2021 and is designated Class II. Reason for recall: Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by… The recall status is terminated (terminated Jul 21, 2023). Affected quantity: 2058 licenses worldwide, 79 licenses in US.

Recall details

Product Type
Devices
Report Date
Sep 22, 2021
Initiation Date
Jun 24, 2021
Termination Date
Jul 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2058 licenses worldwide, 79 licenses in US

Product description

cobas infinity central lab running software version 3.01.03 through 3.02.08, Catalog#: 07154003001

Reason for recall

Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by your Laboratory Information System (LIS) as a false positive or negative result. It should be noted that the "correct" result would still be available on the instrument.

Distribution pattern

US Nationwide distribution

Code information

UDI: 04015630936007; All systems running software version 3.01.03 - 3.02.08

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2444-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2444-2021. Report a data issue: hello@regdatalab.com.